MOLECULAR HETEROGENEITY OF MANTLE CELL LYMPHOMA
EHA Library, Oriane Cédile, 181143
NOVEL TARGET GENES OF DEREGULATED MIRNAS IN DLBCL REVEALED BY ENDOGENOUS AGO2 PAR-CLIP
EHA Library, Marta Fernandez-Mercado, 181144
DARATUMUMAB, A NOVEL HUMAN CD38 MONOCLONAL ANTIBODYFOR THE TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA
EHA Library, Alba Matas-Céspedes, 181145
ECTONUCLEOTIDASES CD39/CD73 ARE HIGHLY EXPRESSED ON ATLL CELLS AND RESPONSIBLE FOR GENERATING AMP/ADENOSINE.
EHA Library, Yasuhiro NAGATE, 181146
ACTIVATION OF SYK TYROSINE KINASE PLAYS A ROLE IN RESISTANCE AGAINST THE SELECTIVE BTK INHIBITOR ONO/GS-4059 IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL).
EHA Library, Kohki Tsukamoto, 181148
STRO-001, A NOVEL ANTI-CD74 ANTIBODY DRUG CONJUGATE (ADC) FOR TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMA (NHL)
EHA Library, Arturo Molina, 181149
DETECTING MALIGNANT B-CELLS IN CEREBROSPINAL FLUID: DOES THE IDEAL METHOD EXIST?
EHA Library, Magali Le Garff-Tavernier, 181150
THE SYK INHIBITOR R406 DRAMATICALLY INCREASES THE SENSITIVITY OF GCB AND ABC DLBCL CELL LINES TO THE BCL-2 INHIBITOR VENETOCLAX
EHA Library, Binu Sasi, 181151
VΒ EXPRESSION ASSESSMENT AND CLONALITY DETECTION IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) BY FLOW CYTOMETRY (FCM) AND NEXT GENERATION SEQUENCING (NGS): A COMPARISON OF BOTH METHODS
EHA Library, Michaela Kotrová, 181152
IRF4 EXPRESSION IS ASSOCIATED WITH RESPONSE OF MANTLE CELL LYMPHOMA TO BRUTON’S TYROSINE KINASE INHIBITORS
EHA Library, Hannah Thompson, 181153
LOSS OF TPL2 KINASE ACCELERATES MYC-INDUCED LYMPHOMAGENESIS
EHA Library, ELIAS STAGAKIS, 181154
LIQUID BIOPSY: DECIPHERING A SIGNATURE OF CIRCULATING MICRORNAS AS NOVEL NON-INVASIVE BIOMARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Francesco Marchesi, 181155
INTRACELLULAR CALCIUM AND METABOLISM HAVE CRITICAL ROLES IN DETERMINING ANTI-CD20 ANTIBODY EFFICACY IN DLBCL
EHA Library, Emma Vilventhraraja, 181156
CYCLIN D1 ONCOGENIC OVEREXPRESSION LEADS TO A GLOBAL TRANSCRIPTIONAL DOWNREGULATION IN MALIGNANT LYMPHOID CELLS
EHA Library, Robert Albero, 181157
MICROENVIRONMENTAL EXPRESSION OF IMMUNOREGULATORY MOLECULES AND CYTOKINES IN CLASSICAL HODGKIN LYMPHOMA PROGNOSIS
EHA Library, Olga Novosad, 181158
AN IN VIVO TRACEABLE AND MULTIPLEXING CRISPR/CAS9 GENOME EDITING SYSTEM
EHA Library, T Niu, 181159
HDAC6 INHIBITION SENSITIZES TUMOR CELLS TO ANTI-CD20 IMMUNOTHERAPY IN VIVO
EHA Library, Malgorzata Bobrowicz, 181161
NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T-CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY.
EHA Library, Morgane Cheminant, 181162
HIGH EXPRESSION LEVELS OF MIR23A CLUSTER IN DLBCL ANTAGONIZE INDUCTION OF APOPTOSIS
EHA Library, Sonja Eberth, 181163
PLASMA CELLS ARISE FROM DIFFERENTIATION OF CLONAL LYMPHOCYTES AND SECRETE IGM IN WALDENSTRÖM MACROGLOBULINEMIA
EHA Library, Dipti Talaulikar, 181164
LENALIDOMIDE (LEN) DRIVES PROGRAMMED DEATH-1 (PD1) PATHWAY UPREGULATION IN A TUMOR MICROENVIRONMENT (TME) MODEL OF ACTIVATED LOW-GRADE LYMPHOMA CELLS
EHA Library, Fortunato Morabito, 181166
IDENTIFICATION AND DIAGNOSTIC APPLICATION OF GENOMIC NPM-ALK FUSION SEQUENCES IN ANAPLASTIC LARGE CELL LYMPHOMAS
EHA Library, Manuela Krumbholz, 181167
ARSENIC TRIOXIDE TARGETS BCL6 FOR DEGRADATION AND INHIBITS THE PROLIFERATION OF BCL6-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Wai Choi Eric Tse, 181168
PROTEOMIC PHOSPHOSITE ANALYSIS IDENTIFIED CRUCIAL NIPA SERINE RESIDUES FOR NPM-ALK-MEDIATED TRANSFORMATION
EHA Library, Anina Gengenbacher, 181169
APPLICATION OF CELL-OF-ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV-RELATED DIFFUSE LARGE B CELL LYMPHOMAS
EHA Library, Jose Tomás Navarro Ferrando, 181170
CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO
EHA Library, Alexander Deutsch, 181171
EPSTEIN-BARR VIRUS LOAD IN PLASMA IS AN EARLY BIOMARKER OF HIV-RELATED LYMPHOMA
EHA Library, Josep Muncunill, 181172
CLONOTYPE AND MUTATIONAL PATTERN IN TCRGD LARGE GRANULAR LYMPHOCYTE LEUKEMIA
EHA Library, Antonella Teramo, 181173
INCREASED EXPRESSION OF IRF8 IN TUMOR CELLS INHIBITS THE GENERATION OF TH17 CELLS AND PREDICTS UNFAVORABLE SURVIVAL OF DIFFUSE LARGE B CELL LYMPHOMA PATIENTS
EHA Library, Qingshan Li, 181174
GENOMIC PROFILING OF BCL2 AND MYC DOUBLE EXPRESSOR DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Vaidas Dirsé, 181175
ARQ 531, A REVERSIBLE BTK INHIBITOR, DEMONSTRATES POTENT ANTI-TUMOR ACTIVITY IN ABC-DLBCL AND GCB-DLBCL
EHA Library, Sudharshan Eathiraj, 181176
ROLE OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY
EHA Library, Luigi Rigacci, 181177
CDK4/6-INHIBITION BY ABEMACICLIB INDUCES POTENT EARLY G1-ARREST IN MCL CELL LINES AND SHOWS SEQUENCE-SPECIFIC INTERACTIONS WITH CYTARABINE AND IBRUTINIB
EHA Library, Luca Fischer, 181178
CD8+ T-CELL CLONES PERSISTENT IN BONE MARROW AND PERIPHERIAL BLOOD DURING COURSE OF CD4+ ANGIOIMMUNOBLASTIC LYMPHOMA
EHA Library, Andrey Sudarikov, 181179
CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA SHOWED FREQUENT MYC EXPRESSION AND AGGRESSIVE CLINICAL BEHAVIOR
EHA Library, Ji Eun Kim, 181180
REACTIVE FLORID B-LINEAGE LYMPHOID PROLIFERATIONS IN HIV INFECTION MAY MIMIC LYMPHOMA
EHA Library, Tracey Wiggill, 181181
MICROVESSEL DENSITY IN CD30 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMAS.
EHA Library, Francesco Gaudio, 181182
ANTIGEN SELECTION PROMOTES CLONAL CYTOTOXIC T-CELL RESPONSES: HIGH-THROUGHPUT IMMUNOGENETIC EVIDENCE
EHA Library, Evangelia Stalika, 181183
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES
EHA Library, Irene Della Starza, 181184
RHOA GLY17VAL MUTATION AND T-CELL CLONALITY ANALYSIS IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
EHA Library, Yulia Sidorova, 181185
USEFULNESS OF CHITOTRIOSIDASE ACTIVITY, CCL18/PARC, 7-KETOCHOLESTEROL AND GLUCOSYLSPHINGOSINE CONCENTRATIONS FOR SCREENING OF LYSOSOMAL STORAGE DISORDERS.
EHA Library, Pilar Irun, 181186
THE VALUE OF SOLUBLE IL-2R APLHA SUBUNIT MEASUREMENT IN CSF OF CHILDREN WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH): PRELIMINARY OBSERVATIONS
EHA Library, Yasmine El Chazli, 181187
GAUCHER DISEASE PATIENTS EXHIBIT A HIGH EXPRESSION OF LIPOCALINE (LCN2) AS POSSIBLE BIOMARKER OF RESIDUAL DISEASE ACTIVITY. EXPLORATORY STUDY AND CORRELATION WITH OTHER CYTOKINES.
EHA Library, Marcio Andrade-Campos, 181188
COMPARISON OF TREATMENT AND OUTCOMES BETWEEN ACQUIRED PRIMARY AND SECONDARY THROMBOTIC THROMBOCYTOPENIC PURPURA
EHA Library, Shin Hnin Wai, 181189
EVANS SYNDROME IN CHILDHOOD: LONG TERM SINGLE CENTER EXPERIENCE
EHA Library, Marina Economou, 181190
LOW DOSE RITUXIMAB IS A USEFUL ADDITION TO CORTICOSTEROIDS FOR NEWLY DIAGNOSED PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA
EHA Library, Andres Gómez-De León, 181191
INFECTIOUS COMPLICATIONS IN PRIMARY AUTOIMMUNE NEUTROPENIA OF CHILDHOOD
EHA Library, Alexandros Makis, 181192
NEW EPO-RECEPTOR MUTATION IN A -17 YEAR OLD WOMAN WITH ERYTHROCYTOSIS
EHA Library, Beatriz Robredo, 181193
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILDREN
EHA Library, Zafer Salcioglu, 181194
ABNORMAL MONOCYTE POPULATIONS IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONID IDIOPATHIC NEUTROPENIA
EHA Library, Maria Velegraki, 181195
DIAGNOSTIC VALUE OF CELL BOUND AND CIRCULATING ANTI-NEUTROPHIL ANTIBODY DETECTION IN PEDIATRIC NEUTROPENIA
EHA Library, Laura Porretti, 181196
INAPPROPRIATE TREATMENT COULD MASK COBALAMIN DEFICIENCY: ROLE OF METHYLMALONIC ACID EVALUATION.
EHA Library, Angel F Remacha, 181197
RITUXIMAB IN AUTOIMMUNE HEMOLYTIC ANEMIA OF INFANCY
EHA Library, Marina Economou, 181199
EARLY LESSONS FROM WHOLE-GENOME SEQUENCING IN THE CLINICAL DIAGNOSIS OF RARE INHERITED ANAEMIAS
EHA Library, Noemi , 181200
CONGENITAL ERYTHROCYTOSIS: DISCOVER OF A NEW MUTATION
EHA Library, João Barradas, 181201
A RETROSPECTIVE STUDY OF THE THROMBOTIC MICROANGIOPATHIES DIAGNOSED IN THE LAST 17 YEARS IN ONE SINGLE CENTRE
EHA Library, Ada Esteban Figuerola, 181202
CHILDREN WITH CHRONIC-REFRACTORY AUTOIMMUNE CYTOPENIAS: A SINGLE CENTER EXPERIENCE
EHA Library, Tuba Hilkay Karapınar, 181203
INHERITED PROTHROMBOTIC RISK FACTORS IN TURKISH CHILDREN WITH HEREDITARY ANGIOEDEMA. SINGLE CENTER
EHA Library, Turkan Patıroglu, 181204
FLOW CYTOMETRIC ANALYSIS OF TISSUE SAMPLES IN 42 ADULT PATIENTS WITH MALIGNANCY-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
EHA Library, Monika Klimkowska, 181205
BLEEDING IN PRIMARY IMMUNE THROMBOCYTOPENIA: WHO ARE MOST AT RISK?
EHA Library, Umesh Doobaree, 181206
A MULTICENTRE, SINGLE ARM, OPEN LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF ELTROMBOPAG IN PATIENTS WITH SEVERE PERSISTENT IMMUNE THROMBOCYTOPENIC PURPURA (ITP) WITHIN SIX MONTHS OF DIAGNOSIS
EHA Library, Huyen Tran, 181207
A NOVEL RUNX1 MUTATION IN FAMILY WITH FAMILIAL PLATELET DISORDER WITH PREDISPOSITION TO ACUTE MYELOGENOUS LEUKEMIA
EHA Library, Lenka Krupkova, 181208
PROFILING CIRCULATING MICRORNAS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) TO EXPLORE THE ROLE OF MICRORNAS AND POSSIBLE BIOLOGICAL PATHWAYS INVOLVED IN THE PATHOGENESIS OF ITP
EHA Library, Lamya Garabet, 181210
NORDIC COUNTRY PATIENT REGISTRY FOR IMMUNE THROMBOCYTOPENIA (NCPRITP): A COHORT OF PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA IN DENMARK, SWEDEN, AND NORWAY
EHA Library, Waleed Ghanima, 181211
EPIDEMIOLOGY OF PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS IN RUSSIAN FEDERATION (RESULTS OF REGISTRY OF NATIONAL HEMATOLOGIC ASSOCIATION)
EHA Library, Anait Melikyan, 181212
ELTROMBOPAG (EPAG) FOR THE TREATMENT OF PATIENTS AGED ≥65 YEARS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP): SAFETY AND EFFICACY RESULTS FROM THE EXTEND STUDY
EHA Library, Abdulgabar Salama, 181213
SAFETY AND EFFICACY OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Yuji Yamada, 181214
CHILDHOOD IMMUNE THROMBOCYTOPENIA: A NATIONWIDE COHORT STUDY ON CONDITION MANAGEMENT AND OUTCOMES
EHA Library, Thomas Pincez, 181215
SIROLIMUS FOR THE TREATMENT OF CHILDREN WITH IMMUNE THROMBOCYTOPENIA AND EVANS SYNDROME. A SINGLE CENTRE EXPERIENCE
EHA Library, Maurizio Miano, 181216
ASSESSMENT OF ROMIPLOSTIM SELF-ADMINISTRATION BY PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA AND CAREGIVERS FOLLOWING RECEIPT OF HOME ADMINISTRATION TRAINING (HAT) MATERIALS: A CROSS-SECTIONAL STUDY
EHA Library, Martin Schipperus, 181217
FCΓIIA 131 H/R (A>G) RECEPTOR GENE POLYMORPHISM IN PATIENTS OF PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
EHA Library, Anil Tripathi, 181218
SHORT- AND LONG-TERM RESULTS OF FIRST LINE THERAPY WITH PULSED HIGH-DOSE DEXAMETHASONE IN ADULT IMMUNE THROMBOCYTOPENIA PATIENTS: A RETROSPECTIVE SINGLE-CENTER REPORT.
EHA Library, LARA CRUCITTI, 181219
EFFECT OF OSELTAMIVIR TREATMENT ON PLATELET COUNTS
EHA Library, Nuria Revilla, 181220
CLINICAL UTILITY OF CARDIAC MRI IN IMMUNE MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
EHA Library, Ferras Alwan, 181221
THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
EHA Library, Isik Kaygusuz Atagunduz, 181222
PD-1 AND CTLA-4 POLYMORPHISMS AFFECT THE SUSCEPTIBILITY AND CLINICAL FEATURES OF CHRONIC IMMUNE THROMBOCYTOPENIA.
EHA Library, Rumi Ino, 181223
IS THE SPLENECTOMY OUTCOME PREDICTABLE IN PATIENTS WITH ITP?
EHA Library, Mirjana Mitrovic, 181224
FINAL RESULTS FROM AN OBSERVATIONAL STUDY (PLATEAU) OF ADULT PATIENTS TREATED WITH ROMIPLOSTIM FOR PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ROUTINE CLINICAL PRACTICE IN GERMANY
EHA Library, Marcel Reiser, 181225
THE CLINICAL UTILITY OF NEUROPSYCHOLOGY TESTING IN IMMUNE MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA
EHA Library, Ferras Alwan, 181226
FIVE NEW CASES OF HERMANSKY-PUDLAK SYNDROME: IDENTIFICATION OF NOVEL GENETIC VARIANTS IN HPS4 AND HPS3 ASSOCIATED TO RELEVANT CLINICAL COMPLICATIONS
EHA Library, Jose Maria Bastida Bermejo, 181227
CHARACTERIZATION OF PLATELET ACTIVATION MARKERS IN EARLY ONSET PREECLAMPSIA
EHA Library, Daniel Angelov, 181228
PRIMARY ITP IN ADULTS TREATED WITH ELTROMBOPAG: A RETROSPECTIVE STUDY USING DATA FROM THE UNITED KINGDOM ADULT IMMUNE THROMBOCYTOPENIA REGISTRY.
EHA Library, Drew Provan, 181229
EFFICACY OF TPO-MIMETICS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA
EHA Library, Francesca Bacchiarri, 181230
PREVALENCE AND RISK FACTORS FOR THROMBOSIS IN ADULT ITP PATIENTS
EHA Library, Alicia Rovó, 181231
OSELTAMIVIR FOR THE TREATMENT OF ITP PATIENTS NOT RESPONDING TO CONVENTIONAL TREATMENT: BIOLOGICAL CHARACTERIZATION AND CLINICAL RESPONSES
EHA Library, Nuria Revilla, 181232
BORTEZOMIB THERAPY IS ASSOCIATED WITH SIGNIFICANT RESOURCE IMPLICATIONS FOR BOTH PATIENTS AND PROVIDERS: RESULTS OF A TIME-IN-MOTION STUDY
EHA Library, Karthik Ramasamy, 181233
HOSPITAL CARE AT HOME ADMINISTRATION OF SUBCUTANEOUS AZACITIDINE IS FEASIBLE AND PREFERRED BY PATIENTS COMPARED TO HOSPITAL ADMINISTRATION: A FRENCH REGIONAL HEMATOLOGY NETWORK EXPERIENCE
EHA Library, Mohamed Touati, 181234
USE OF COMBINED ORAL FENTANYL CITRATE (ACTIQ®) AND MIDAZOLAM AS PREMEDICATION FOR BONE MARROW BIOPSY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A RANDOMIZED CONTROLLED PATIENT BLINDED CLINICAL TRIAL
EHA Library, Claudio Cerchione, 181235
ASSESSMENT OF THE ECONOMIC IMPACT OF HORSE-ATG IN SWEDEN FOR APLASTIC ANAEMIA
EHA Library, Vaibhav Katkade, 181236
NEUROPSYCHOLOGICAL ANALYSIS OF LONG-TERM CONSEQUENCES OF ANTINEOPLASTIC TREATMENT
EHA Library, Sergei Khrushchev, 181237
A CLINICAL AUDIT OF NUTRITIONAL SCREENING AND SUPPORT OF HOSPITALIZED PATIENTS WITH HEMATOLOGIC DISEASES.
EHA Library, Panagiotis Diamantopoulos, 181238
ASSESSING REAL-WORLD TREATMENT PATTERNS, OUTCOMES AND RESOURCE USE ACROSS EUROPE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS POST AUTOLOGOUS STEM CELL TRANSPLANT
EHA Library, Sujith Dhanasiri, 181239
NUMBER-NEEDED-TO-TREAT (NNT) AND COST OF RESPONSES ACHIEVED IN TYROSINE KINASE INHIBITOR (TKI) TREATMENT OF REFRACTORY CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN THE UNITED STATES (US)
EHA Library, M. Yair Levy, 181240
THE COST-EFFECTIVENESS OF PEGASPARGASE FOR FIRST-LINE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIA: A COST-UTILITY ANALYSIS
EHA Library, Clare Rowntree, 181241
IMPACT OF VENETOCLAX ON THE QUALITY OF LIFE OF PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PHASE 2, OPEN-LABEL STUDY OF VENETOCLAX (ABT-199/GDC-0199) MONOTHERAPY
EHA Library, William Wierda, 181242
WHICH HAEMATOLOGICAL CONDITIONS CAN THIRD YEAR MEDICAL STUDENTS RECOGNISE INTERPRETING FULL BLOOD COUNT RESULTS?
EHA Library, Silvia Lovato, 181243
LONGITUDINAL ASSOCIATIONS BETWEEN HEALTH-RELATED QUALITY OF LIFE AND HEALTHCARE UTILIZATION IN AL AMYLOIDOSIS
EHA Library, Kristen McCausland, 181244
SAFETY, FEASIBILITY AND EFFECTIVENESS OF ELECTRICAL MUSCLE STIMULATION IN HOSPITALIZED PATIENTS UNDERGOING AUTOLOGOUS OR ALLOGENEIC STEM CELL TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY
EHA Library, Anna Klostermann, 181245
MYELOMA PATIENT VALUE MAPPING: A DISCRETE CHOICE EXPERIMENT
EHA Library, Jayne Galinsky, 181246
COST-MINIMIZATION ANALYSIS OF RITUXIMAB SUBCUTANEOUS FORMULATION VERSUS INTRAVENOUS ADMINISTRATION OF RITUXIMAB FOR THE TREATMENT OF NON-HODGKIN’S LYMPHOMA IN THE REPUBLIC OF MACEDONIA
EHA Library, Oliver Nikolov, 181247

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings